Form 4: Balchem Director Acquires 870 Restricted Shares

Balchem Corporation Director Matthew David Wineinger acquired 870 shares of common stock as restricted stock, vesting in one year.

Summary

• Matthew David Wineinger, a Director of Balchem Corporation (BCPC), acquired 870 shares of common stock.
• The acquisition was a grant of restricted stock, with a transaction date of February 11, 2026.
• These shares vest one year after the grant date, subject to transfer restrictions.
• Following this transaction, Wineinger beneficially owns 8,012 shares of common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive, routine transaction, reflecting standard director compensation and aligning the director's interests with long-term shareholder value.

Positives

• Director Matthew David Wineinger received a grant of 870 restricted shares, aligning his interests with shareholders.
• The grant indicates continued commitment and incentivization for the director.

Risks

• The restricted stock is subject to transfer restrictions and a one-year vesting period, meaning the shares are not immediately liquid or fully owned until vesting.

Future Outlook

The restricted stock grant, vesting one year from the transaction date, indicates a future alignment of the director's interests with long-term company performance.

Management Comments

• Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

Industry Context

StockSavvy.ai notes that restricted stock grants are a common form of executive and director compensation across various industries, including specialty chemicals and nutrition, aligning management incentives with shareholder value creation over the long term. This practice is consistent with corporate governance trends aimed at fostering sustained performance.

Comparison to Industry Standards

• Restricted stock grants are a standard component of director compensation packages in publicly traded companies, comparable to practices at peers like Ingredion (INGR) or Kerry Group (KRYAY) which also utilize equity awards to incentivize long-term commitment and performance.
• The one-year vesting period is a common, though sometimes shorter, duration for such grants, with many companies opting for multi-year vesting schedules for broader executive compensation.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholder value through equity ownership.
• Director (Matthew David Wineinger): Receives additional equity compensation, subject to vesting.

Next Steps

• The 870 restricted shares will vest on February 11, 2027.

Key Dates

Recommendation

This Form 4 reports a routine restricted stock grant to a director, which is a standard compensation practice. While it aligns the director's interests with shareholders, it does not provide new fundamental information to alter an existing investment thesis or warrant a 'buy' or 'sell' recommendation based solely on this filing.

Keywords

Balchem, BCPC, Form 4, Insider Trading, Restricted Stock, Director Compensation, Equity Grant, Matthew David Wineinger